Sanofi ties price increases to growth rate; Regeneron to target 7,000 docs on new eczema drug Dupixent; NIH and biotech execs meet White House officials
Susannah Fox, formerly of HHS
April 4, 2017
11:00 am
Susannah Fox is the former chief technology officer for HHS.